Therapeutic significance of the beta-receptor blockade in lithium-induced tremor. Therapeutic trials with Pindolol and Practolol
Floru, L.; Tegeler, J.
Die Medizinische Welt 25(11): 450
1974
ISSN/ISBN: 0025-8512 PMID: 4150261 Document Number: 71754
Document emailed within 1 workday
Related Documents
Höffgen, K.U.; Laudage, G.; von Lilienfeld-Toal, H.; Gugler, R.; Bodem, G. 1976: Relationship between the blood level and the inhibitory effect of renin activation under beta-receptor blockade using pindolol Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1337-1339Mehta, A.B.; Gandhi, M.J. 1976: Therapeutic beta-adrenergic blockade Journal of the Association of Physicians of India 24(11): 795-797
Jensen, G.; Boesgaard, S.; Aldershvile, J. 1999: Beta-blockade--a new therapeutic modality in chronic heart insufficiency Ugeskrift for Laeger 161(37): 5152-5155
Dilsaver, S.C. 1984: Lithium's effects on muscarinic receptor binding parameters: a relationship to therapeutic efficacy? Biological Psychiatry 19(11): 1551-1565
Wuppermann, D.; Zimmermann, F.; Friedrich, L. 1978: Comparative study on the effects of alprenolol, bunitrolol, ethaverine, oxprenolol, papaverine, practolol, pindolol, pronethalol, propranolol, toliprolol and verapamil on cardiac and bronchial beta-receptors Arzneimittel-Forschung 28(5): 794-798
Levy, B. 1973: Practolol blockade of cardiac but not vascular or uterine beta-adrenergic receptors in the anesthetized cat Archives Internationales de Pharmacodynamie et de Therapie 204(1): 143-146
Cachin, Y.; Flamant, R.; Richard, J.; Sancho-Garnier, H. 1982: From empiricism to therapeutic trials. Or how statistical methods can contribute to the improvement of therapeutic protocols in cervicofacial oncology Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 99(1-2): 47-52
Kruse, J.M.; Ereshefsky, L.; Scavone, M. 1984: Treatment of lithium-induced tremor with nadolol Clinical Pharmacy 3(3): 299-301
van den Berg, W.; Fokkens, J.; Leferink, J.G.; Kreukniet, J.; Maes, R.A.; Bruynzeel, P.L. 1982: Tremor measurement in asthma. II. Changes after terbutaline administration suggesting beta-adrenergic blockade European Journal of Respiratory Diseases 63(5): 392-398
Erbil, Y.; Eroglu, L.; Forth, W.; Schmolke, G.; Elsenhans, B.; Schümann, K. 1993: On the capacity of the rat intestine to excrete lithium ions at therapeutic and toxic plasma lithium concentrations Journal of Trace Elements and Electrolytes in Health and Disease 7(2): 95-99
Gaillard-Sizaret, C.; Gaillard, P. 1979: Neuroleptic-induced tardive dyskinesia: recent pathophysiological data, therapeutic trials Therapie 34(5): 555-574
Lumholtz, I.B. 1975: Nurses' drug information. Therapeutic main group: beta receptor blockaders. Their use in cardiology. 2 Sygeplejersken 75(18): 13
Hammerl, H.; Kränzl, C.; Nebosis, G.; Pichler, O.; Studlar, M. 1972: Metabolic studies and therapeutic experiences with the beta-receptor blockader 4-(2-hydroxy-3-isopropylamino-propoxy)-indol (LB 46) Arzneimittel-Forschung 22(6): 1055-1061
Masini, V.; Ceci, V.; Malinconico, U.; Milazzotto, F. 1981: Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy Giornale Italiano di Cardiologia 11(11): 1729-1737
Bauer, V. 1981: Action of metipranolol, practolol, and pindolol on the taenia coli of the guinea-pig Bratislavske Lekarske Listy 76(4): 481-487
Tupone, D.; Cetas, J.S.; Morrison, S.F. 2016: Hibernation, Hypothermia and a Possible Therapeutic "Shifted Homeostasis" Induced by Central Activation of A1 Adenosine Receptor (A1AR) Nihon Shinkei Seishin Yakurigaku Zasshi 36(2): 51-54
Newton, G.E.; Parker, J.D. 1996: Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure Circulation 94(3): 353-358
Bergmann, J.F.; Lagier, G.; Calvo, F.; Chazelle, F.; Caulin, C. 1988: Independent controls of quality in therapeutic trials. Apropos of an experience of 11 external audits of clinical investigators performed in 2 European multicenter trials Therapie 43(5): 379-384
Gandhi, D.N.; Gulati, O.D.; Hemavathi, K.G. 1981: Blockade of 5-hydroxytryptamine-induced responses of rat seminal vesicle by lithium-possible mediation through calcium exchange Archives Internationales de Pharmacodynamie et de Therapie 253(2): 220-232
Schou, M. 1959: Therapeutic and toxic properties of lithium Acta Psychiatrica Scandinavica. Supplementum 34(136): 51-55